title: Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour. Maligne Keimzelltumoren Study Group.
abstract: Vaginal yolk-sec tumours are usually incurable unless radical surgery is done. We have shown, however, that, neoadjuvant cisplatin-based chemotherapy with conservative surgery is effective in the management of these tumours, and results in a good survival rate, unlike germ-cell tumours of other origin.
authors.forename: C
authors.initials: C
authors.lastname: Mauz-Körholz
authors.forename: D
authors.initials: D
authors.lastname: Harms
authors.forename: G
authors.initials: G
authors.lastname: Calaminus
authors.forename: U
authors.initials: U
authors.lastname: Göbel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018240:Endodermal Sinus Tumor / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D007223:Infant; D015996:Survival Rate; D014625:Vaginal Neoplasms / Q000188:drug therapy* / Q000601:surgery*